Frontiers in oncology

publication venue for

Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment. 2022
A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Reported in ALL. 2019
Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence. 2019
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma.. 13. 2023
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients.. 13. 2023
Geographic variation in malignant cardiac tumors and their outcomes: SEER database analysis.. 13. 2023
Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer.. 12. 2022
The initial experience of MRI-guided precision prone breast irradiation with daily adaptive planning in treating early stage breast cancer patients.. 12. 2022
Quality of life and function after rectal cancer surgery with and without sphincter preservation.. 12. 2022
Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge.. 12. 2022
Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer.. 12. 2022
Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 Cases.. 12. 2022
Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study.. 12. 2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 ^low Mice.. 12. 2022
Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study.. 12. 2022
All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism.. 12. 2022
PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes.. 11. 2022
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study.. 11. 2022
Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma.. 11. 2021
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer.. 11. 2021
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients.. 11. 2021
Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice.. 11. 2021
Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS-NF-кB-NLRP3 Axis.. 11. 2021
A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study.. 11. 2021
A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.. 11. 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML.. 11. 2021
Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy.. 11. 2021
Early Cumulative Fluid Balance and Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients With Acute Respiratory Failure: A Multicenter Study.. 11. 2021
G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models.. 11. 2021
Antidiabetic Agent DPP-4i Facilitates Murine Breast Cancer Metastasis by Oncogenic ROS-NRF2-HO-1 Axis via a Positive NRF2-HO-1 Feedback Loop.. 11. 2021
Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.. 11. 2021
Changes in Urologic Operative Practice at the Beginning of the COVID-19 Pandemic in a Large, National Cohort.. 11. 2021
The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm.. 11. 2021
Delirium in Children Undergoing Hematopoietic Cell Transplantation: A Multi-Institutional Point Prevalence Study.. 11. 2021
Challenges in Diversity, Equity, and Inclusion in Research and Clinical Oncology.. 11. 2021
Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation.. 11. 2021
Prostac: A New Composite Score With Potential Predictive Value in Prostate Cancer.. 11. 2021
In Memory of Professor John Gordon McVie: Bringing People Together 13 January 1945 - 20 January 2021.. 11. 2021
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer.. 11. 2021
Comparison Between Urothelial and Non-Urothelial Urethral Cancer.. 10. 2021
Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study.. 10. 2020
CAR Chase: Where Do Engineered Cells Go in Humans?. 10. 2020
Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model.. 10. 2020
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer.. 10. 2020
Anterior Clinoidal Meningiomas: Meningeal Anatomical Considerations and Surgical Implications.. 10. 2020
Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.. 9. 2019
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.. 9. 2019
Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis.. 9. 2019
Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018.. 9. 2019
Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study.. 9. 2019
A Care Process Model to Deliver ¹⁷⁷Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors.. 8. 2019
BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker.. 8. 2019
Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer.. 8. 2018
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.. 8. 2018
Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship.. 8. 2018
Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer.. 8. 2018
A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer.. 8. 2018
MYC Immunohistochemistry Predicts MYC Rearrangements by FISH.. 7. 2017
Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.. 7. 2017
Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer.. 7. 2017
The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.. 7. 2017
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.. 6. 2016
Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer.. 5. 2015
Novel Treatments for Thymoma and Thymic Carcinoma.. 5. 2015
Use of a Flexible Inflatable Multi-Channel Applicator for Vaginal Brachytherapy in the Management of Gynecologic Cancer.. 5. 2015
Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.. 5. 2015
P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas.. 5. 2015
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens.. 5. 2015
Prom1 function in development, intestinal inflammation, and intestinal tumorigenesis.. 4. 2014
Toxicity and disease-related outcomes after radiotherapy for head and neck cancer in human immunodeficiency virus-positive patients.. 4. 2014
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.. 4. 2014
Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer.. 4. 2014
Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study.. 4. 2014
Sequential administration of carbon nanotubes and near-infrared radiation for the treatment of gliomas.. 4. 2014
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancer.. 3. 2013
Quality of life following amputation or limb preservation in patients with lower extremity bone sarcoma.. 3. 2013
Additive Influence of Extracellular pH, Oxygen Tension, and Pressure on Invasiveness and Survival of Human Osteosarcoma Cells.. 3. 2013
Radiotherapy effects on anti-tumor immunity: implications for cancer treatment.. 3. 2013
Is there a role for an external beam boost in cervical cancer radiotherapy?. 3. 2013
Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.. 2. 2013
An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors.. 2. 2012
Radiation as an immunological adjuvant: current evidence on dose and fractionation.. 2. 2012
Isolation and characterization of circulating tumor cells in prostate cancer.. 2. 2012
Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.. 2. 2012
Do circulating tumor cells play a role in coagulation and thrombosis?. 2. 2012
Role of T lymphocytes in tumor response to radiotherapy.. 2. 2012
Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide.. 2. 2012
The convergence of radiation and immunogenic cell death signaling pathways.. 2. 2012
Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells.. 2. 2012
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma.. 2. 2012
Comparison of Acute and Late Toxicity of Two Regimens of 3- and 5-Week Concomitant Boost Prone IMRT to Standard 6-Week Breast Radiotherapy.. 2. 2012
ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy.. 2. 2012
End stage and chronic kidney disease: associations with renal cancer.. 2. 2012
Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease.. 2. 2012
The role of a prone setup in breast radiation therapy.. 1. 2011
Grand challenges in oncology.. 1. 2011
Cell death signaling and anticancer therapy.. 1. 2011
Challenges in cancer molecular targets and therapeutics.. 1. 2011
The grand challenges to cellular and molecular oncology.. 1. 2011
Past, present, and future of molecular and cellular oncology.. 1. 2011
The underexplored links between cancer and the internal body climate: Implications for cancer prevention and treatment.. 12. 2022
Machine Learning Models for Classifying High- and Low-Grade Gliomas: A Systematic Review and Quality of Reporting Analysis.. 12. 2022
Treatment Strategies and Outcomes of Pediatric Esthesioneuroblastoma: A Systematic Review.. 10. 2020
Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem".. 5. 2015
Editorial: Measurable residual disease in hematologic malignancies.. 13. 2023
Editorial: Prognostic factors in non-small cell lung cancer.. 13. 2023
Editorial: Molecular genetics and therapeutic advances in renal carcinoma.. 12. 2023
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy.. 10. 2020
Editorial: PVT1 in Cancer.. 10. 2020
Editorial: EBV-Associated Carcinomas: Presence, Role, and Prevention Strategies.. 8. 2018
Weaving the nest: extracellular matrix roles in pre-metastatic niche formation. 2023
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies. 2023
A review of research on the intersection between breast cancer and cardiovascular research in the Women's Health Initiative (WHI). 2023
Tyrosine kinases in nodal peripheral T-cell lymphomas. 2023
MRI-LINAC: A transformative technology in radiation oncology. 2023
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer. 2023
The potential impact of melanosomal pH and metabolism on melanoma. 2022
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance. 2022
Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology. 2022
Treatment of Retinoblastoma: What Is the Latest and What Is the Future. 2022
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor. 2021
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression. 2021
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer. 2021
Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma. 2021
Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis. 2021
Obese Adipose Tissue as a Driver of Breast Cancer Growth and Development: Update and Emerging Evidence. 2021
Platelets and Metastasis: New Implications of an Old Interplay. 2020
Oncogenic Role of PVT1 and Therapeutic Implications. 2020
Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus. 2019
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma. 2019
PVT1 Signaling Is a Mediator of Cancer Progression. 2019
Metadherin: A Therapeutic Target in Multiple Cancers. 2019
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy. 2019
Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors. 2019
Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway. 2018
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer. 2018
The Mitochondrial Unfolded Protein Response as a Non-Oncogene Addiction to Support Adaptation to Stress during Transformation in Cancer and Beyond. 2017
Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer. 2017
Disparities in Gynecological Malignancies. 2016
Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs. 2015
Immunotherapy of Childhood Sarcomas. 2015
Locally advanced breast cancer - strategies for developing nations. 2015
Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies. 2015
Training global oncologists: addressing the global cancer control problem. 2015
Targeting neuroendocrine prostate cancer: molecular and clinical perspectives. 2015
Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia. 2015
CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic. 2015
Combinations of immunotherapy and radiation in cancer therapy. 2014
The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. 2014
The many faces of neuroendocrine differentiation in prostate cancer progression. 2014
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy. 2013

VIVO Weill Cornell Medical College

Frontiers in oncology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)